CVS Health Forecast, price target & analysts
CVS Health Target price 2026 - Analyst rating & recommendation
CVS Health Classifications & Recommendation:
CVS Health Price Target
| Target Price | $96.90 |
| Price | $80.13 |
| Potential |
20.93%
register free of charge
|
| Number of Estimates | 28 |
|
28 Analysts have issued a price target CVS Health 2027 .
The average CVS Health target price is $96.90.
This is
20.93%
register free of charge
$110.25
37.59%
register free of charge
$79.79
0.42%
register free of charge
|
|
| A rating was issued by 33 analysts: 27 Analysts recommend CVS Health to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the CVS Health stock has an average upside potential 2027 of
20.93%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 372.81 | 403.97 |
| 4.20% | 8.36% | |
| Net Margin | 1.24% | 2.11% |
| 46.93% | 70.49% |
30 Analysts have issued a sales forecast CVS Health 2025 . The average CVS Health sales estimate is
This results in the following potential growth metrics:
30 CVS Health Analysts have issued a net profit forecast 2025. The average CVS Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 3.66 | 6.72 |
| 43.43% | 83.61% | |
| P/E | 11.93 | |
| EV/Sales | 0.39 |
30 Analysts have issued a CVS Health forecast for earnings per share. The average CVS Health EPS is
This results in the following potential growth metrics and future valuations:
Current CVS Health Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Locked
➜
Locked
|
Locked | Dec 17 2025 |
| Bernstein |
Locked
➜
Locked
|
Locked | Dec 12 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Dec 10 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Dec 10 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Dec 10 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Dec 10 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Dec 10 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JP Morgan:
Locked
➜
Locked
|
Dec 17 2025 |
|
Locked
Bernstein:
Locked
➜
Locked
|
Dec 12 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Dec 10 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Dec 10 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Dec 10 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Dec 10 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Dec 10 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
